Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

Critical Care Medicine

Volumn 33, Issue 7, 2005, Pages 1529-1533

  Boselli, Emmanuel ^a   Breilh, Dominique ^c   Rimmelé, Thomas ^a   Djabarouti, Sarah ^c   Toutain, Jérôme ^c   Chassard, Dominique ^b   Saux, Marie Claude ^c   Allaouchiche, Bernard ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Intensive care; Linezolid; Lung diffusion; Pharmacokinetics; Ventilator associated pneumonia

Indexed keywords

LINEZOLID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; GRAM POSITIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE; LUNG ALVEOLUS EPITHELIUM; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEADY STATE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 22144468784     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000168206.59873.80     Document Type: Article

References (24)

1. Diekema DJ, Jones RN: Oxazolidinone antibiotics. Lancet 2001; 358:1975-1982
2. Bouza E, Muñoz P: Linezolid: Pharmacokinetic characteristics and clinical studies. Clin Microbiol Infect 2001; 7(Suppl 4):75-82
3. Conte JE Jr, Golden JA, Kipps J, et al: Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 2002; 46:1475-1480
4. Gee T, Ellis R, Marshall G, et al: Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 2001; 45:1843-1846
5. Honeybourne D, Tobin C, Jevons G, et al: Intrapulmonary penetration of linezolid. J Antimicrob Chemother 2003; 51:1431-1434
6. Kollef MH, Rello J, Cammarata SK, et al: Clinical cure and survival in Gram-positive ventilator-associated pneumonia: Retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 2004; 30:388-394
7. Bergogne-Bérézin E: New concepts in the pulmonary disposition of antibiotics. Pulm Pharmacol 1995; 8:65-81
8. Boselli E, Allaouchiche B: Diffusion pulmonaire des antibiotiques. Analyse critique de la littérature. Ann Fr Anesth Réanim 2001; 20:612-630
9. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140
10. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002:165:867-903
11. Pham LH, Brun-Buisson C, Legrand P, et al: Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 1991; 143:1055-1061
12. Boselli E, Breilh D, Cannesson M, et al: Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med 2004; 30:976-979
13. Boselli E, Breilh D, Duflo F, et al: Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med 2003; 31:2102-2106
14. Boselli E, Breilh D, Rimmelé T, et al: Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia. Intensive Care Med 2004; 30:989-991
15. Boselli E, Breilh D, Rimmelé T, et al: Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia. Crit Care Med 2005; 33:104-109
16. Toutain J, Boselli E, Djabarouti S, et al: Determination of linezolid in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 813:145-150
17. MacGowan AP: Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother 2003; 51(Suppl 2):ii17-25
18. Stalker DJ, Jungbluth GL, Hopkins NK, et al: Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. J Antimicrob Chemother 2003; 51:1239-1246
19. Rayner CR, Forrest A, Meagher AK, et al: Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet 2003; 42:1411-1423
20. Liu P, Muller M, Derendorf H: Rational dosing of antibiotics: The use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002; 19:285-290
21. Andes D, van Ogtrop ML, Peng J, et al: In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 2002; 46:3484-3489
22. Craig WA: Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 2003; 17:479-501
23. Yamazaki K, Ogura S, Ishizaka A, et al: Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med 2003; 168:1304-1307
24. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963